Has Teva (TEVA) Run Too Far After Its 102% One-Year Share Price Surge?
- If you are wondering whether Teva Pharmaceutical Industries is still good value after its recent run, this article walks through what the current share price might be implying about the company.
- Teva’s share price last closed at US$33.91, with returns of 6.6% over the past 30 days, 9.6% year to date and 102.1% over the last year. The 3 year and 5 year returns sit at 242.5% and 210.5% respectively, which raises the question of how much optimism is already reflected in the price.
- Recent coverage around Teva has focused on its position in the global generics and specialty pharmaceuticals space and investor attention on how it is managing its business mix and balance sheet. This backdrop helps explain why the market has been reassessing…
Source link
